FDA/Generic Communications Plan Restoring Best Of Past Practices
This article was originally published in The Pink Sheet Daily
Executive Summary
Office of Generic Drugs wants to allow project managers to inform sponsors of major deficiencies before ‘complete response’ letter as part of ‘go/no go’ effort.